Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARR
5026
PUT
Armour Residential REIT
ARR
$2.35B
| $3.18M | ﹤0.01% |
179,620
-13,580
| -7% | -$225K |
|
5027
Integra LifeSciences
IART
$1.38B
| $3.18M | ﹤0.01% |
+255,807
| New | +$3.4M |
|
5028
Hackett Group
HCKT
$290M
| $3.18M | ﹤0.01% |
161,842
+16,108
| +11% | +$306K |
|
5029
CALL
Rapid7
RPD
$726M
| $3.18M | ﹤0.01% |
208,900
+90,100
| +76% | +$1.48M |
|
5030
CALL
Elanco Animal Health
ELAN
$13.1B
| $3.17M | ﹤0.01% |
139,900
-23,600
| -14% | -$514K |
|
|
SMLR
5031
CALL
DELISTED
Semler Scientific
SMLR
| $3.17M | ﹤0.01% |
207,000
-132,000
| -39% | -$2.99M |
|
5032
Seneca Foods Class A
SENEA
$1.16B
| $3.16M | ﹤0.01% |
28,582
+14,518
| +103% | +$1.66M |
|
|
APPX
5033
CALL
Tradr 2X Long APP Daily ETF
APPX
$66M
| $3.16M | ﹤0.01% |
29,733
-867
| -3% | -$91.4K |
|
5034
CALL
Global Ship Lease
GSL
$1.54B
| $3.16M | ﹤0.01% |
90,100
-58,200
| -39% | -$1.89M |
|
5035
PUT
PagSeguro Digital
PAGS
$2.63B
| $3.16M | ﹤0.01% |
327,400
-175,000
| -35% | -$1.68M |
|
5036
CALL
AllianceBernstein
AB
$3.47B
| $3.16M | ﹤0.01% |
82,000
+3,400
| +4% | +$135K |
|
5037
Pliant Therapeutics
PLRX
$65M
| $3.15M | ﹤0.01% |
2,583,332
+243,864
| +10% | +$366K |
|
|
RDAGU
5038
Republic Digital Acquisition Co Unit
RDAGU
$231M
| $3.15M | ﹤0.01% |
302,039
-105,900
| -26% | -$1.12M |
|
5039
WSFS Financial
WSFS
$4.23B
| $3.14M | ﹤0.01% |
56,895
-96,339
| -63% | -$5.27M |
|
5040
CALL
West Pharmaceutical
WST
$24.7B
| $3.14M | ﹤0.01% |
11,400
-36,100
| -76% | -$9.87M |
|
5041
Qfin Holdings
QFIN
$1.6B
| $3.13M | ﹤0.01% |
162,658
+62,100
| +62% | +$1.39M |
|
5042
Nomura Holdings
NMR
$29B
| $3.13M | ﹤0.01% |
+373,587
| New | +$2.79M |
|
5043
Avery Dennison
AVY
$13.4B
| $3.13M | ﹤0.01% |
17,222
-74,057
| -81% | -$12.8M |
|
|
ASTX
5044
CALL
Tradr 2X Long ASTS Daily ETF
ASTX
$394M
| $3.13M | ﹤0.01% |
76,400
+23,700
| +45% | +$1.16M |
|
5045
Cactus
WHD
$5.28B
| $3.12M | ﹤0.01% |
68,258
-253,652
| -79% | -$10.6M |
|
5046
PUT
YieldMax NVDA Option Income Strategy ETF
NVDY
$1.45B
| $3.12M | ﹤0.01% |
213,300
-35,700
| -14% | -$549K |
|
5047
SES AI
SES
$189M
| $3.12M | ﹤0.01% |
1,730,875
-2,364,858
| -58% | -$5.3M |
|
|
APLS
5048
PUT
DELISTED
Apellis Pharmaceuticals
APLS
| $3.11M | ﹤0.01% |
124,000
+10,200
| +9% | +$239K |
|
5049
Vanguard Industrials ETF
VIS
$8.42B
| $3.11M | ﹤0.01% |
10,438
+8,973
| +612% | +$2.66M |
|
5050
abrdn Physical Precious Metals Basket Shares ETF
GLTR
$2.61B
| $3.11M | ﹤0.01% |
+15,147
| New | +$2.78M |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.